National Institute Of Oncology, Hungary
Clinical trials sponsored by National Institute Of Oncology, Hungary, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Single-Fraction very accelerated partial breast irradiation (sfVAPBI) in Low-Risk invasive or ductal in situ breast carcinoma - phase II multicenter trial Results expected Jul 2027 (estimated)